Literature DB >> 3989801

Examination of the causes of early pregnancy-associated thrombocytopenia in mice.

C O'Neill.   

Abstract

In mice, neither the bleeding time nor the clotting time of whole blood was different on Day 2 of pregnancy compared with pseudopregnancy. Standardization of the platelet concentration to 10(6)/microliters plasma resulted in a significant reduction in the clotting time of plasma from pregnant animals. This reduction was not due to an increase in the intrinsic or extrinsic pathways of the coagulation cascade but to enhanced platelet factor III activity, indicating increased platelet activation and consumption. Increased activation was not due to immunological recognition of the embryo because thrombocytopenia occurred after syngeneic and allogeneic matings of inbred strains of mice and also after parthenogenetic activation of ova in situ. Injection of embryo culture medium into splenectomized mice induced a significant dose-dependent thrombocytopenia. It occurred within 10 min after injection and persisted for up to 2 h. There was no reduction in platelet count when animals were injected with culture media in which unfertilized ova had been incubated. Early pregnancy-associated thrombocytopenia was caused by the production of platelet-activating factors by the fertilized eggs. The induction of thrombocytopenia by embryo culture media displayed a dose-response curve that was parallel to that of the platelet-activating factor, 1-0-alkyl-2-acetyl-sn-glycero(3)phosphocholine.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3989801     DOI: 10.1530/jrf.0.0730567

Source DB:  PubMed          Journal:  J Reprod Fertil        ISSN: 0022-4251


  9 in total

1.  Early pregnancy in human may not be associated with mild thrombocytopenia.

Authors:  W S Yeung; Y F Chan; W K So; P C Ho; S T Chan
Journal:  J Assist Reprod Genet       Date:  1992-02       Impact factor: 3.412

2.  Embryo-derived platelet activating factor, a marker of embryo quality and viability following ovarian stimulation for in vitro fertilization.

Authors:  U Punjabi; A Vereecken; L Delbeke; M Angle; M Gielis; J Gerris; J Johnston; P P Buytaert
Journal:  J In Vitro Fert Embryo Transf       Date:  1990-12

3.  Peripheral blood platelet counts in the management of very early pregnancy failure following gamete intrafallopian transfer.

Authors:  J Evans; L Gregory; S Walker
Journal:  J In Vitro Fert Embryo Transf       Date:  1990-02

4.  Autoradiographic localization of platelet-activating factor (PAF) binding sites in the rabbit endometrium during the peri-implantation period.

Authors:  G B Kudolo; M Kasamo; M J Harper
Journal:  Cell Tissue Res       Date:  1991-08       Impact factor: 5.249

5.  Effects of platelet activating factor on mouse embryo implantation in vitro.

Authors:  O Nishi; T Tominaga; Y Goto; K Hayashi; T Mori
Journal:  J Assist Reprod Genet       Date:  1995-05       Impact factor: 3.412

6.  Platelet-activating factor acetylhydrolase activity in maternal, fetal, and newborn rabbit plasma during pregnancy and lactation.

Authors:  N Maki; D R Hoffman; J M Johnston
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

7.  Effects of low-dose human chorionic gonadotropin on corpus luteum function after embryo transfer.

Authors:  M M Mahadevan; A Leader; P J Taylor
Journal:  J In Vitro Fert Embryo Transf       Date:  1985-12

8.  Maternal blood platelet physiology and luteal-phase endocrinology as a means of monitoring pre- and postimplantation embryo viability following in vitro fertilization.

Authors:  C O'Neill; A A Gidley-Baird; I L Pike; R N Porter; M J Sinosich; D M Saunders
Journal:  J In Vitro Fert Embryo Transf       Date:  1985-06

9.  Effect of platelet-activating factor on lipoprotein lipase and blood lipids.

Authors:  K Mimura; S Yukawa; Y Mori; K Okada; M Mune; O Nishikawa; A Hibino; M Sonobe; T Goto; H Nomoto
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.